{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:32:05Z","timestamp":1781335925474,"version":"3.54.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.05.056","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T23:42:18Z","timestamp":1592523738000},"page":"5119-5122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Human papillomavirus (HPV) vaccine utilization among adults (18\u201329\u00a0years), BRFSS 2015"],"prefix":"10.1016","volume":"38","author":[{"given":"R. Constance","family":"Wiener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6924-8248","authenticated-orcid":false,"given":"Patricia A.","family":"Findley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjana","family":"Dwibedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Sambamoorthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.056_b0005","unstructured":"McQuillan GM, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R. Prevalence of HPV in adults aged 18-69: United States, 2011-2014. Hyattsville, MD: National Center for Health Statistics; 2017. Report No.: NCHS data brief, no 280."},{"issue":"11","key":"10.1016\/j.vaccine.2020.05.056_b0010","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.15633","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices","volume":"19","author":"Meites","year":"2019","journal-title":"Am J Transplant"},{"issue":"33","key":"10.1016\/j.vaccine.2020.05.056_b0015","doi-asserted-by":"crossref","first-page":"909","DOI":"10.15585\/mmwr.mm6733a1","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2017","volume":"67","author":"Walker","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.056_b0020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ypmed.2008.11.010","article-title":"Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey\u2014Adult 2007","volume":"48","author":"Jain","year":"2009","journal-title":"Prev Med"},{"issue":"11","key":"10.1016\/j.vaccine.2020.05.056_b0025","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.05.056_b0030","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6549a5","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination\u2014updated recommendations of the Advisory Committee on Immunization Practices","volume":"65","author":"Meites","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2020.05.056_b0035","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/21645515.2019.1565267","article-title":"Addressing HPV vaccine myths: practical information for healthcare providers","volume":"15","author":"Bednarczyk","year":"2019","journal-title":"Human Vacc Immunotherapeut"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.056_b0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/jwh.2008.0920","article-title":"The HPV vaccine: a content analysis of online news stories","volume":"18","author":"Habel","year":"2009","journal-title":"J Women's Health"},{"key":"10.1016\/j.vaccine.2020.05.056_b0045","unstructured":"Centers for Disease Control and Prevention. HPV Vaccine Schedule and Dosing 2019 [Available from: https:\/\/www.cdc.gov\/hpv\/hcp\/schedules-recommendations.html."},{"issue":"4","key":"10.1016\/j.vaccine.2020.05.056_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"de Sanjos\u00e9","year":"2019","journal-title":"JNCI Cancer Spectrum"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.056_b0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10900-017-0420-x","article-title":"US primary care clinics\u2019 experiences during introduction of the 9-valent HPV vaccine","volume":"43","author":"Kornides","year":"2018","journal-title":"J Community Health"},{"issue":"7","key":"10.1016\/j.vaccine.2020.05.056_b0060","first-page":"234","article-title":"A Survey of Physicians' Attitudes and Practices about the Human Papillomavirus (HPV) Vaccine in Hawai \u2018i","volume":"74","author":"Soon","year":"2015","journal-title":"Hawai'i J Med Publ Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:39Z","timestamp":1759401879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":12,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20307015"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus (HPV) vaccine utilization among adults (18\u201329\u00a0years), BRFSS 2015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}